We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

103 hedge funds and large institutions have $269M invested in Albany Molecular Research Inc in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

18% more capital invested

Capital invested by funds: $228M → $269M (+$40.6M)

16% more call options, than puts

Call options by funds: $501K | Put options by funds: $433K

5% more funds holding

Funds holding: 98 → 103 (+5)

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

Holders
103
Holders Change
+5
Holders Change %
+5.1%
% of All Funds
3.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
36
Reduced
35
Closed
13
Calls
$501K
Puts
$433K
Net Calls
+$68K
Net Calls Change
+$378K

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$25M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$6.66M
3
GAM
Gotham Asset Management
New York
+$2.81M
4
Northern Trust
Northern Trust
Illinois
+$2.06M
5
Invesco
Invesco
Georgia
+$1.72M

Top Sellers

Rank Fund Capital Flow
1
SFM
Systematic Financial Management
New Jersey
-$3.2M
2
Morgan Stanley
Morgan Stanley
New York
-$3.06M
3
BIT
BlackRock Institutional Trust
California
-$2.93M
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$2.39M
5
TC
TFS Capital
Pennsylvania
-$2.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2.04M +$666K +54,116 +52%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$1.77M +$102K +8,325 +6%
Goldman Sachs
28
Goldman Sachs
New York
$1.75M +$1.68M +136,179 New
SFM
29
Systematic Financial Management
New Jersey
$1.5M -$3.2M -259,780 -69%
PP
30
PDT Partners
New York
$1.5M -$43.1K -3,500 -3%
GCP
31
GSA Capital Partners
United Kingdom
$1.44M +$441K +35,855 +47%
PPA
32
Parametric Portfolio Associates
Washington
$1.38M +$741K +60,274 +129%
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.36M +$467K +38,000 +59%
WIC
34
Woodmont Investment Counsel
Tennessee
$1.35M -$461K -37,465 -26%
TCIM
35
TIAA CREF Investment Management
New York
$1.33M -$63.3K -5,147 -5%
CBOA
36
Commonwealth Bank of Australia
Australia
$1.33M +$889K +72,282 +232%
AG
37
Algert Global
California
$1.32M +$50.9K +4,140 +4%
TCM
38
Timpani Capital Management
Wisconsin
$1.31M -$465K -37,819 -27%
Charles Schwab
39
Charles Schwab
California
$1.25M -$667K -54,200 -36%
AI
40
Analytic Investors
California
$1.2M +$1.15M +93,161 New
Bessemer Group
41
Bessemer Group
New Jersey
$1.18M – – –
BIM
42
BlackRock Investment Management
Delaware
$1.05M +$31.9K +2,591 +3%
CS
43
Credit Suisse
Switzerland
$938K +$98.6K +8,017 +12%
SO
44
STRS Ohio
Ohio
$851K -$28.3K -2,300 -3%
AQR Capital Management
45
AQR Capital Management
Connecticut
$831K +$95.2K +7,737 +14%
Axa
46
Axa
France
$815K +$118K +9,600 +18%
PAM
47
Panagora Asset Management
Massachusetts
$809K +$15.4K +1,251 +2%
NI
48
Numeric Investors
Massachusetts
$782K +$183K +14,901 +33%
CAM
49
ClariVest Asset Management
California
$760K +$443K +36,035 +157%
Citadel Advisors
50
Citadel Advisors
Florida
$729K -$1.51M -122,861 -68%
1
2
3 4 5

AMRI Hedge Fund Activity: Q3 2013 in Review

103 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2013, worth a combined $269M — up 18% from $228M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AMRI positions and 13 closed out — a net gain of 5 holders — while 36 added to existing stakes and 35 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $25M. The largest seller was Systematic Financial Management, cutting an estimated $3.2M.

  • 103 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2013, up from 98 in Q2 2013.
  • Funds reported $269M of Albany Molecular Research Inc stock for Q3 2013, up 18% quarter-over-quarter.
  • 18 funds opened new Albany Molecular Research Inc positions in Q3 2013 and 13 closed out, a net change of +5 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2013 was Visium Asset Management, an estimated $25M added.
  • The largest Albany Molecular Research Inc seller in Q3 2013 was Systematic Financial Management, an estimated $3.2M sold.

Based on aggregated 13F filings for Q3 2013.